EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Metformin use and hospital attendance‐related resources utilization among diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based cohort study

Yan Hiu Athena Lee iD, Jeremy Man Ho Hui iD, Cheuk To Chung, Kang Liu, Edward Christopher Dee, Kenrick Ng, Gary Tse iD, Jeffrey Shi Kai Chan iD, Chi Fai Ng iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.5651 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Cancer Medicine, 2023. Verfasst von Yan Hiu Athena Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Metformin, Diabetes Mellitus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Androgen deprivation therapy (ADT), used increasingly in the treatment of prostate cancer (PCa), negatively influences glycemic control in diabetes and is associated with an increased risk of diabetes complications where hospitalization commonly ensues. Metformin could decrease the metabolic consequences of ADT and enhance its effect. This study examined the association of metformin use with healthcare resources utilization among diabetic, PCa patients receiving ADT.

Methods

Diabetic adults with PCa on ADT in Hong Kong between December 1999 and March 2021 were identified. Patients with

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMetforminDiabetes MellitusMaleHumansAndrogen AntagonistsAndrogensCohort StudiesHospitals

Stichwörter der Autor:innen

androgen deprivation therapydiabetesmedical costsmetforminprostate cancer

Substanzen

MetforminAndrogen AntagonistsAndrogens

Autor:innen und Institutionen

  • Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Cardio-oncology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.
  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
  • Kent and Medway Medical School, University of Kent, Canterbury, United Kingdom.

ORCID-Profile: Yan Hiu Athena Lee, Jeremy Man Ho Hui, Gary Tse, Jeffrey Shi Kai Chan, Chi Fai Ng

Förderung

  • NCI NIH HHS

Zitieren

APA

Lee, Y. H. A., Hui, J. M. H., Chung, C. T., Liu, K., Dee, E. C., Ng, K., Tse, G., Chan, J. S. K., & Ng, C. F. (2023). Metformin use and hospital attendance‐related resources utilization among diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based cohort study. Cancer Medicine. https://doi.org/10.1002/cam4.5651

Vancouver

Lee YHA, Hui JMH, Chung CT, Liu K, Dee EC, Ng K, et al. Metformin use and hospital attendance‐related resources utilization among diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based cohort study. Cancer Medicine. 2023. doi:10.1002/cam4.5651

BibTeX
@article{Lee2023,
  author = {Lee, Yan Hiu Athena and Hui, Jeremy Man Ho and Chung, Cheuk To and Liu, Kang and Dee, Edward Christopher and Ng, Kenrick and Tse, Gary and Chan, Jeffrey Shi Kai and Ng, Chi Fai},
  title = {Metformin use and hospital attendance‐related resources utilization among diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based cohort study},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.5651}
}
Kostenlos starten →